Home / Inspections / 778012

FDA Inspection 778012 — Everest Life Sciences LLC

Everest Life Sciences LLC — FEI 2243092

The FDA completed an inspection of Everest Life Sciences LLC on April 16, 2012 in Plainsboro, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 16, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Plainsboro, NJ (United States)

Facility

Other inspections at this facility

  • 1267697 (VAI Wed Apr 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1071273 (VAI Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1063269 (NAI Fri Jul 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 964002 (NAI Wed Mar 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 710185 (VAI Fri Feb 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources